Frazier Life Sciences Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3M | Hold |
|
|||||
|
2025
Q1 | $56.4M | Hold |
|
|||||
|
2024
Q4 | $41.4M | Buy |
|
|||||
|
2024
Q3 | $42.7M | Hold |
|
|||||
|
2024
Q2 | $43.4M | Hold |
|
|||||
|
2024
Q1 | $43.7M | Buy |
|
|||||
|
2023
Q4 | $44.4M | Buy |
|
|||||
|
2023
Q3 | $31.2M | Hold |
|
|||||
|
2023
Q2 | $29.1M | Hold |
|
|||||
|
2023
Q1 | $25.5M | Hold |
|
|||||
|
2022
Q4 | $21.9M | Buy |
|
|||||
|
2022
Q3 | $22.8M | Hold |
|
|||||
|
2022
Q2 | $15.5M | Hold |
|
|||||
|
2022
Q1 | $23.2M | Buy |
|